Publicacións en colaboración con investigadores/as de Universitat Autònoma de Barcelona (28)

2024

  1. Sex-Stratified Genome-Wide Association Study in the Spanish Population Identifies a Novel Locus for Lacunar Stroke

    Stroke, Vol. 55, Núm. 10, pp. 2462-2471

2023

  1. CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome

    Neurology, Vol. 100, Núm. 23, pp. E2386-E2397

  2. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 861-871

2022

  1. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort

    Neurology, Vol. 99, Núm. 12, pp. E1299-E1313

  3. Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 2, pp. 122-131

  4. Multi-Ancestry GWAS reveals excitotoxicity associated with outcome after ischaemic stroke

    Brain, Vol. 145, Núm. 7, pp. 2394-2406

  5. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  6. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Article targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke: Safety and optimal dose selection in a randomized clinical trial

    Antioxidants, Vol. 10, Núm. 8

  2. Clinical characteristics and outcomes of thymoma-associated myasthenia gravis

    European Journal of Neurology, Vol. 28, Núm. 6, pp. 2083-2091

  3. Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome

    Stroke, Vol. 52, Núm. 1, pp. 132-141

  4. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  5. Single nucleotide variations in ZBTB46 are associated with post-thrombolytic parenchymal haematoma

    Brain, Vol. 144, Núm. 8, pp. 2416-2426

2020

  1. Cold stress protein RBM3 responds to hypothermia and is associated with good stroke outcome

    Brain Communications, Vol. 2, Núm. 2

2019

  1. Genome-wide association study of white blood cell counts in patients with ischemic stroke

    Stroke, Vol. 50, Núm. 12, pp. 3618-3621

  2. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 90, Núm. 5, pp. 576-585

2018

  1. The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis

    Annals of Clinical and Translational Neurology, Vol. 5, Núm. 6, pp. 710-716

2017

  1. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15

    Journal of Neuroinflammation, Vol. 14, Núm. 1

  2. Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain

    Scientific Reports, Vol. 7, Núm. 1